期刊文献+

纳米裸晶的平衡溶解度与粒径无关 被引量:2

Equilibrium solubility of naked nanocrystals is not size-dependent
下载PDF
导出
摘要 目的研究Ostwald-Freundlich方程提出的粒径与溶解度的关系。方法采用稀释溶解法测定以"bottom-up"方法所得辅酶Q10(coenzyme Q10,CoQ10)球形纳米裸晶在不同溶剂系统中的溶解度。结果原料药(约30μm)与不同粒径(85.1、77.4、58.9 nm)CoQ10纳米裸晶在4种醇-水系统中的平衡溶解度分别为0.82-0.88、4.40-4.74、16.70-17.43、31.75-33.04 mg.L-1。结论纳米裸晶的平衡溶解度与粒径无关。 Objective To study the relationship between particle size and solubility based on the Ostwald-Freundlich equation.Methods The dilution-dissolution method was used to determine the solubility of naked and spherical coenzyme Q10 nanocrystals prepared by a "bottom-up" approach.Results The equilibrium solubilities of the bulk drug(about 30 μm)and different nanocrystals(with particle sizes of 85.1,77.4,58.9 nm)in four kinds of ethanol-water solutions with various ethanol concentrations were 0.82-0.88,4.40-4.74,16.70-17.43,31.75-33.04 mg·L-1,respectively.Conclusions The equilibrium solubility is not related to the particle size.
作者 邓意辉 孙姣
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第4期258-259,共2页 Journal of Shenyang Pharmaceutical University
基金 国家重点基础研究发展计划(973计划)项目(2009CB930300)
关键词 溶解度 平衡溶解度 界面溶解度 Ostwald-Freundlich方程 纳米裸晶 辅酶Q10 solubility equilibrium solubility interfacial solubility Ostwald-Freundlich equation naked nanocrystal coenzyme Q10
  • 相关文献

参考文献32

  • 1邓意辉,孙姣.纳米裸晶的平衡溶解度与粒径无关[J].沈阳药科大学学报,2011,28(4):258-259. 被引量:2
  • 2单亚.滤膜吸附对部分口服药物溶出度的干扰试验研究[J].安徽医药,2007,11(2):118-119. 被引量:7
  • 3朱孟府,龚承元,苏建勇,陈慧敏.荷电微孔滤膜对水中达旦黄吸附性能的研究[J].工业水处理,2001,21(7):23-25. 被引量:8
  • 4Shoufeng Li,SuiMing Wong,Sundeep Sethia,Hassan Almoazen,Yatindra M. Joshi,Abu T. M. Serajuddin.Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH[J]. Pharmaceutical Research . 2005 (4) 被引量:1
  • 5Wenju Wu,George H. Nancollas.A New Understanding of the Relationship Between Solubility and Particle Size[J]. Journal of Solution Chemistry . 1998 (6) 被引量:1
  • 6JINNO J I,KAMADA N,MIYAKE M,et al.Effect ofparticle size reduction on dissolution and oral ab-sorption of a poorly water-soluble drug,cilostazol,inbeagle dogs. Journal of Controlled Release . 2006 被引量:1
  • 7BIRADAR S V,PATIL A R,SUDARSAN G V,etal.A comparative study of approaches used to im-prove solubility of roxithromycin. Powder Techn-ol . 2006 被引量:1
  • 8SHERIDAN P L,BUCKTON G,STOREY D E.The ex-tent of errors associated with contact angles II.Factorsaffecting data obtained using a Wilhelmy plate tech-nique for powders. International Journal of Pharmaceutics . 1994 被引量:1
  • 9JIANG Q,LU H M.Size dependent interface energyand its applications. Surface Science Reports . 2008 被引量:1
  • 10BUCKTONG,GILLH.The importance of surface ener-getics of powders for drug delivery and the establish-ment of inverse gas chromatography. Adv Drug De-liver Rev . 2007 被引量:1

二级参考文献38

  • 1苏建勇,龚承元,朱孟府.荷电微孔滤膜去除细菌内毒素的试验研究[J].军事医学科学院院刊,1995,19(4):289-292. 被引量:20
  • 2齐钦华.微孔滤材的性能与应用[J].安徽医药,2005,9(4):301-302. 被引量:4
  • 3单亚.滤膜吸附对部分口服药物溶出度的干扰试验研究[J].安徽医药,2007,11(2):118-119. 被引量:7
  • 4国家药药典委员会编.中华人民共和国药典.二部附录X C,北京:化学工业出版社,2005. 被引量:1
  • 5中国药品生物制品检定所编.中国药品检验标准操作规范.北京:中国医药科技出版社,2005. 被引量:2
  • 6国家药药典委员会编.中华人民共和国药典.二部,北京:化学工业出版社,2005. 被引量:1
  • 7Shoufeng Li,SuiMing Wong,Sundeep Sethia,Hassan Almoazen,Yatindra M. Joshi,Abu T. M. Serajuddin.Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH[J]. Pharmaceutical Research . 2005 (4) 被引量:1
  • 8Wenju Wu,George H. Nancollas.A New Understanding of the Relationship Between Solubility and Particle Size[J]. Journal of Solution Chemistry . 1998 (6) 被引量:1
  • 9JINNO J I,KAMADA N,MIYAKE M,et al.Effect ofparticle size reduction on dissolution and oral ab-sorption of a poorly water-soluble drug,cilostazol,inbeagle dogs. Journal of Controlled Release . 2006 被引量:1
  • 10BIRADAR S V,PATIL A R,SUDARSAN G V,etal.A comparative study of approaches used to im-prove solubility of roxithromycin. Powder Techn-ol . 2006 被引量:1

共引文献12

同被引文献60

  • 1单亚.滤膜吸附对部分口服药物溶出度的干扰试验研究[J].安徽医药,2007,11(2):118-119. 被引量:7
  • 2ALSENZ J, KANSY M. High throughput solubility measurement in drug discovery and developmentl J]. Adv Drug Deliv Rev ,2007,59(7 ) :546 -567. 被引量:1
  • 3HUANG L F,TONG W Q. Impact of solid state prop- erties on developability assessment of drug candidates [ J]. Adv Drug Deliv Rev,2004,56(3 ) :321 - 334. 被引量:1
  • 4AGANTA S, PAXTON J W, BAGULEY B C, et al. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery [ J ]. Int J Pharm, 2009,367 ( 1/2 ) : 179 - 186. 被引量:1
  • 5DOLENC A, KRISTL J, BAUMGARTNER S, et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets [ J ]- Int J Pharm,2009, 376(1/2) :204 -212. 被引量:1
  • 6JUNGHANNS J, MULLER R H. Nanocrystal technol- ogy, drug delivery and clinical applications [ J ]. Int J Nanomed,2008,3 (3) :295 - 309. 被引量:1
  • 7WU Wen-ju, NANCOLLAS G H. A new understand- ing of the relationship between solubility and particle size[ J]1. J Solution Chem, 1998,27 (6) : 521 - 531. 被引量:1
  • 8DUNDON M L, JR E M. The solubility and surface energy of calcium sulfate[ J]. J Am Chem Soc, 1923, 45( 11 ) :2479 -2485. 被引量:1
  • 9HECQ J, DELEERS M, FANARA D, et al. Prepara- tion and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine [ J ]. Int J Pharm,2005,299(1/2) :167 -177. 被引量:1
  • 10JINNO J I, KAMADA N, MIYAKE M, et al. Effect of particle size reduction on dissolution and oral absorp- tion of a poorly water-soluble drug, cilostazol,in bea- gle dogs [ J ]. J Control Release, 2006, 111 ( 1/2 ) : 56 - 64. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部